Multidrug resistance during cancer chemotherapy — biotechnological solutions to a clinical problem

This publication has 31 references indexed in Scilit:

• Effect of d,l-verapamil, verapamil enantiomers and verapamil metabolites on the binding of vincristine to α1-acid glycoprotein
  European Journal Of Cancer, 1993
• Overcoming Multidrug Resistance in Human Tumor Cells Using Free and Liposomally Encapsulated Antisense Oligodeoxynucleotides
  Biochemical and Biophysical Research Communications, 1993
• Transcription factor based therapeutics: drugs of the future?
  Trends in Biotechnology, 1993
• PCR-determined expression of the MDR1 gene in chronic lymphocytic leukemia
  Annals of Hematology, 1992
• Effect of liposomes on P-glycoprotein function in multidrug resistant cells
  Biochemical and Biophysical Research Communications, 1992
• Augmentation by Bispecific F(ab′)₂ Reactive with P‐Glycoprotein and CD3 of Cytotoxicity of Human Effector Cells on P‐Glycoprotein Positive Human Renal Cancer Cells
  Japanese Journal of Cancer Research, 1992
• Resistance modification by PSC-833, a novel non-immunosuppressive cyclosporin A
  European Journal of Cancer and Clinical Oncology, 1991
• Reversal of Drug Resistance in a Human Colon Cancer Xenograft Expressing MDR1 Complementary DNA by In Vivo Administration of MRK-16 Monoclonal Antibody
  JNCI Journal of the National Cancer Institute, 1991
• Overcoming Murine Tumor Cell Resistance to Vinblastine by Presentation of the Drug in Multilamellar Liposomes Consisting of Phosphatidylcholine and Phosphatidylserine
  Selective Cancer Therapeutics, 1991
• Enhancement of adriamycin® cytotoxicity in a multidrug resistant Chinese hamster ovary (CHO) subline, CHO-Adrr, by toremifene and its modulation by alpha1 acid glycoprotein
  Materials, 1990